Physician profile
Latonya Brown
NPI 1790767515
$1,828.79
in general payments reported to CMS, 2019-2025
22 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $801 · 2020: $297 · 2021: $210 · 2022: $179 · 2023: $240 · 2024: $102.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $342.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $341.72 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaxosmithkline, LLC. | $387.82 | 2019-2024 | Trelegy Ellipta, Nucala |
| Boehringer Ingelheim Pharmaceuticals, INC. | $303.06 | 2019-2023 | Stiolto Respimat, Ofev |
| Sunovion Pharmaceuticals INC. | $155.24 | 2019-2020 | |
| Astrazeneca Pharmaceuticals LP | $153.69 | 2019-2023 | Breztri, Fasenra, Airsupra |
| Veran Medical Technologies, INC. | $145.00 | 2019-2020 | |
| Takeda Pharmaceuticals U.S.A., INC. | $96.84 | 2019-2022 | |
| Grifols USA, LLC | $86.83 | 2019-2023 | Prolastin-C Liquid |
| Body Vision Medical INC. | $84.70 | 2024 | Lungvision |
| Actelion Pharmaceuticals US, INC. | $79.01 | 2020-2021 | |
| Insmed, INC. | $65.24 | 2019-2023 | Arikayce |
| Genzyme Corporation | $42.79 | 2020-2021 | |
| Mylan Specialty L.P. | $37.30 | 2019 | |
| Pfizer INC. | $28.06 | 2022 | |
| Merck Sharp & Dohme LLC | $25.88 | 2019-2021 | |
| Janssen Pharmaceuticals, INC | $25.04 | 2019 |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Baxter Healthcare | $22.39 | 2023 | Hillrom - Vest System Model 105 Home Care |
| Genentech USA, INC. | $18.50 | 2019 | |
| Regeneron Healthcare Solutions, INC. | $16.55 | 2022 | |
| Advanced Respiratory, INC | $15.85 | 2019 | |
| Shionogi INC | $13.75 | 2019 | |
| Philips North America LLC | $12.85 | 2021 | |
| Gilead Sciences, INC. | $12.40 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Latonya Brown listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.